Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carney

Showing results (81-90 of 584) with videos related to

Pageof 59
Sort By:
British Journal of Pharmacology|February 1, 1981
Stereospecific dextrorphan tolerance in ratsJ M Carney, V L Sirochman
The British Journal of Psychiatry : the Journal of Mental Science|June 2, 2007
Does treating depression improve survival after acute coronary syndrome? Invited commentary on... Effects of antidepressant treatment following myocardial infarctionRobert M Carney, Kenneth E Freedland
The American Journal of Psychiatry|August 31, 2007
Depression and coronary heart disease: more pieces of the puzzleRobert M Carney, Kenneth E Freedland
The American Journal of Medicine|October 29, 2008
Depression in patients with coronary heart diseaseRobert M Carney, Kenneth E Freedland
Psychosomatic Medicine|January 6, 2012
Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease?Robert M Carney, Kenneth E Freedland
Expert Opinion on Pharmacotherapy|September 16, 2011
Agomelatine for the treatment of major depressive disorderRegina M Carney, Richard C Shelton
Nature Reviews. Cardiology|January 6, 2017
Reply: NLRP3 inflammasome as a mechanism linking depression and cardiovascular diseasesRobert M Carney, Kenneth E Freedland
Pharmacology, Biochemistry, and Behavior|April 1, 1986
Chronic exercise produces tolerance to muscarinic antagonists in ratsS B McMaster, J M Carney
Physiology & Behavior|September 1, 1985
Exercise-induced changes in schedule controlled behaviorS B McMaster, J M Carney
Psychosomatic Medicine|May 26, 2023
New Perspectives on Treatment of Depression in Coronary Heart DiseaseRobert M Carney, Kenneth E Freedland
Pageof 59

Showing results (81-90 of 584) with videos related to

Sort By:
Pageof 59
British Journal of Pharmacology|February 1, 1981
Stereospecific dextrorphan tolerance in ratsJ M Carney, V L Sirochman
The British Journal of Psychiatry : the Journal of Mental Science|June 2, 2007
Does treating depression improve survival after acute coronary syndrome? Invited commentary on... Effects of antidepressant treatment following myocardial infarctionRobert M Carney, Kenneth E Freedland
The American Journal of Psychiatry|August 31, 2007
Depression and coronary heart disease: more pieces of the puzzleRobert M Carney, Kenneth E Freedland
The American Journal of Medicine|October 29, 2008
Depression in patients with coronary heart diseaseRobert M Carney, Kenneth E Freedland
Psychosomatic Medicine|January 6, 2012
Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease?Robert M Carney, Kenneth E Freedland
Expert Opinion on Pharmacotherapy|September 16, 2011
Agomelatine for the treatment of major depressive disorderRegina M Carney, Richard C Shelton
Nature Reviews. Cardiology|January 6, 2017
Reply: NLRP3 inflammasome as a mechanism linking depression and cardiovascular diseasesRobert M Carney, Kenneth E Freedland
Pharmacology, Biochemistry, and Behavior|April 1, 1986
Chronic exercise produces tolerance to muscarinic antagonists in ratsS B McMaster, J M Carney
Physiology & Behavior|September 1, 1985
Exercise-induced changes in schedule controlled behaviorS B McMaster, J M Carney
Psychosomatic Medicine|May 26, 2023
New Perspectives on Treatment of Depression in Coronary Heart DiseaseRobert M Carney, Kenneth E Freedland
Pageof 59